BIONTECH SE SPON. ADRS 1 revenue breakdown overview

BIONTECH SE SPON. ADRS 1 revenue for the last year amounted to 3.82 B EUR, the most of which — 3.74 B EUR — came from its highest performing source at the moment, Immunotherapy Technologies, the year earlier bringing 17.00 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought BIONTECH SE SPON. ADRS 1 2.95 B EUR, and the year before that — 12.48 B EUR.